Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice

Molecular Brain Research

Volumn 139, Issue 2, 2005, Pages 341-347

  Salvatore, Michael F ^a   Fisher, Brent ^a   Surgener, Stewart P ^a   Gerhardt, Greg A ^a   Rouault, Tracey ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Dopamine; Iron metabolism; IRP 2; Striatum; Tyrosine hydroxylase

Indexed keywords

DOPAMINE TRANSPORTER; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; SERINE; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; KNOCKOUT MOUSE; MESENCEPHALON; MOUSE; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HOMOVANILLIC ACID; IRON REGULATORY PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PHOSPHORYLATION; SERINE; TYROSINE 3-MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

ANIMALIA;

EID: 24944457215     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2005.06.002     Document Type: Article

References (34)

1. E. Bezard, S. Dovero, C. Prunier, P. Ravenscroft, S. Chalon, D. Guilloteau, A.R. Crossman, B. Bioulac, J.M. Brotchie, and C.E. Gross Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- lesioned Macaque model of Parkinson's disease J. Neurosci. 21 2001 6853 6861
2. S.S. Cooperman, E.G. Meyron-Holtz, H. Olivierre-Wilson, M.C. Ghosh, J.P. McConnell, T.A. Rouault. Microcytic anemia, erythropoietic protoporphyria and neurodegeneration in mice with targeted deletion of iron regulatory protein 2 (in revision).
3. K.L. Double, M. Gerlach, V. Schunemann, A.X. Trautwein, L. Zecca, M. Gallorini, M.B.H. Youdim, P. Riederer, and D. Ben-Shachar Iron-binding characteristics of Neuromelanin of the human substantia nigra Biochem. Pharmacol. 66 2003 489 494
4. B.A. Faucheux, M.E. Martin, C. Beaumont, S. Hunot, J.J. Hauw, Y. Agid, and E.C. Hirsch Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease J. Neurochem. 83 2002 320 330
5. B.A. Faucheux, M.E. Martin, C. Beaumont, J.J. Hauw, Y. Agid, and E.C. Hirsch Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease J. Neurochem. 86 2003 1142 1148
6. J.M. Fearnley, and A.J. Lees Ageing and Parkinson's disease: substantia nigra regional selectivity Brain 114 1991 2283 2301
7. D.M. Gash, Z. Zhang, A. Ovadia, W.A. Cass, A. Yi, L. Simmerman, D. Russell, D. Martin, P.A. Lapchak, F. Collins, B.J. Hoffer, and G.A. Gerhardt Functional recovery in parkinsonian monkeys treated with GDNF Nature 380 1996 252 255
8. M.E. Gotz, K. Double, M. Gerlach, M.B.H. Youdim, and P. Riederer The relevance of iron in the pathogenesis of Parkinson's disease Ann. N. Y. Acad. Sci. 1012 2004 193 208
9. B. Grima, A. Lamouroux, F. Blanot, N.F. Biguet, and J. Mallet Complete coding Sequence of rat tyrosine hydroxylase mRNA Proc. Natl. Acad. Sci. 82 1985 617 621
10. R. Grondin, W.A. Cass, Z. Zhang, J.A. Stanford, D.M. Gash, and G.A. Gerhardt Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged Rhesus monkeys J. Neurosci. 23 2003 1974 1980
11. M. Hall, B. Hoffer, and G.A. Gerhardt Rapid and sensitive determination of catecholamines in small tissue samples by high pressure liquid chromatography coupled with dual-electrode coulometric electrochemical detection LC-GC 7 1989 258 265
12. Y. He, P.S. Thong, T. Lee, S.K. Leong, B.Y. Mao, F. Dong, and F. Watt Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys Free Radical Biol. Med. 35 2003 540 547
13. M.A. Hebert, and G.A. Gerhardt Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats J. Pharmacol. Exp. Ther. 282 1997 760 768
14. M.A. Hebert, and G.A. Gerhardt Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in Fischer 344 rats Brain Res. 797 1998 42 54
15. O. Hornykiewicz, and S.J. Kish Biochemical pathophysiology of Parkinson's disease M.D. Yahr K.J. Bergman Advances in Neurology 1986 Raven Press New York 19 34
16. S. Ichikawa, T. Sasaoka, and T. Nagatsu Primary structure of mouse tyrosine hydroxylase deduced from its cDNA Biochem. Biophys. Res. Commun. 176 1991 1610 1615
17. D. Kaur, F. Yantiri, S. Rajagopaian, J. Kumar, J.Q. Mo, R. Boonplueang, V. Viswanath, R. Jacobs, L. Yang, M.F. Beal, D. DiMonte, I. Volitaskis, L. Ellerby, R.A. Cherny, A.I. Bush, and J.K. Andersen Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease Neuron 37 2003 899 909
18. T. LaVaute, S. Smith, S. Cooperman, K. Iwai, W. Land, E. Meyron-Holtz, S.K. Drake, G. Miller, M. Abu-Asab, M. Tsokos, R. Switzer, A. Grinberg, P. Love, N. Tresser, and T.A. Rouault Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice Nat. Genet. 27 2001 209 214
19. P.L. Lee, T. Gelbart, C. West, C. Halloran, J.C. Sipe, and E. Beutler Polymorphisms in iron-responsive binding protein 2 and lack of association with sporadic Parkinson's disease Mov. Disord. 17 2002 1302 1304
20. A. Leng, A. Mura, B. Hengerer, J. Feldon, and B. Ferger Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice Behav. Brain Res. 154 2004 375 383
21. C.W. Levenson, R.G. Cutler, B. Ladenheim, J.L. Cadet, J. Hare, and M.P. Mattson Role of dietary iron restriction in a mouse model of Parkinson's disease Exp. Neurol. 190 2004 506 514
22. E. Meyron-Holtz, M.C. Ghosh, K. Iwai, T. LaVaute, X. Brazzolotto, U.V. Berger, W. Land, H. Ollivierre-Wilson, A. Grinberg, P. Love, and T.A. Rouault Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis EMBO J. 23 2004 386 395
23. T.A. Rouault Iron on the brain Nat. Genet. 28 2001 230 299
24. T.A. Rouault System iron metabolism: a review and implications for brain iron metabolism Pediatr. Neurol. 25 2001 130 137
25. M.F. Salvatore, A. Garcia-Espana, M. Goldstein, A.Y. Deutch, and J.W. Haycock Stoichiometry of tyrosine hydroxylase phosphorylation in the nigrostriatal and mesolimbic systems in vivo: effects of acute haloperidol and related compounds J. Neurochem. 75 2000 225 232
26. M.F. Salvatore, J.C. Waymire, and J.W. Haycock Depolarization-dependent catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ J. Neurochem. 79 2001 349 360
27. M.F. Salvatore, S. Apparsundaram, and G.A. Gerhardt Decreased plasma membrane expression of striatal dopamine transporter in aging Neurobiol. Aging 24 2003 1147 1154
28. M.F. Salvatore, J.L. Zhang, D.M. Large, P.E. Wilson, C.R. Gash, T.C. Thomas, J.W. Haycock, G. Bing, J.A. Stanford, D. Gash, and G.A. Gerhardt Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra J. Neurochem. 90 2004 245 254
29. S.R. Smith, S. Cooperman, T. Lavaute, N. Tresser, M. Ghosh, E. Meyron-Holtz, W. Land, H. Ollivierre, B. Jortner, R. Switzer, A. Messing, and T.A. Rouault Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies Ann. N. Y. Acad. Sci. 1012 2004 65 83
30. J.A. Stanford, M.A. Hebert, and G.A. Gerhardt Biochemical and anatomical changes in basal ganglia of aging animals P.R. Hobs C.V. Mobbs Functional Neurobiology of Aging 2001 Academic Press San Diego 727 736
31. K.J. Thompson, S. Shoham, and J.R. Connor Iron and neurodegenerative disorders Brain Res. Bull. 55 2001 155 164
32. J.C. Waymire, J.P. Johnson, K. Hummer-Lickteig, A. Lloyd, A. Vigny, and G.L. Craviso Phosphorylation of bovine adrenal chromaffin cell tyrosine hydroxylase: temporal correlation of acetylcholine's effect on site phosphorylation, enzyme activation, and catecholamine synthesis J. Biol. Chem. 263 1991 12439 12447
33. B.H.C. Westerink Sequence and significance of dopamine metabolism in the rat brain Neurochem. Int. 7 1985 221 227
34. L. Zecca, M. Gallorini, V. Schunemann, A.X. Trautwein, M. Gerlach, P. Riederer, P. Vezzoni, and D. Tampellini Iron, neuromelanin, and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes J. Neurochem. 76 2001 1766 1773